Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter

Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter

US Patent 9952232 · Granted Apr 24, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NMR system and methods for multi-parameter metabolic vulnerability index evaluat2024
NMR system and methods for multi-parameter metabolic vulnerability index evaluat2024
Cardiovascular risk evaluations using a risk parameter that includes an HDL and 2024
Cardiovascular risk evaluations using a risk parameter that includes an HDL and 2024
Multiple-marker risk parameters predictive of conversion to diabetes2024
Multiple-marker risk parameters predictive of conversion to diabetes2024
Methods, systems and computer programs for assessing CHD risk using adjusted HDL2024
NMR quantification of TMAO2023
Multi-parameter diabetes risk evaluations2023
Multi-parameter diabetes risk evaluations2023
CHD risk stratification evaluations for subjects with high levels of large HDL-P2023
CHD risk stratification evaluations for subjects with high levels of large HDL-P2023